Lamotrigine Tablet
Product Images NDC 55154-2065

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 55154-2065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1

Figure 1
FDA Label Image

Figure 2

Figure 2
The text suggests that there is data on failure probability, expressed as a percentage, possibly related to a medication called Lamotrigine. The value given for failure probability is 100, with an additional value of 80 that could be related to the same topic. There is also a term "+Censored" that may refer to a subset of data that was not included in the analysis.*
FDA Label Image

Structure

Structure
FDA Label Image

Tablets For Suspension

Tablets For Suspension
FDA Label Image

Tablets

Tablets
FDA Label Image

D3b13712 45d4 3347 E053 2a95a90aa915 00

D3b13712 45d4 3347 E053 2a95a90aa915 00
This is a package of Lamotrigine tablets, USP 100 mg, containing 10 tablets. The package contains a warning that it is not child-resistant and is intended for institutional use only. The tablets are to be dispensed with a medication guide and the usual dosage and storage instructions can be found in the product insert. The package is distributed by American Health Packaging, a subsidiary of AmerisourceBergen Company, and Cardinal Health. NDC number for the drug product is 68382.008 by Zydus Pharmaceuticals USA Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.